Company profile CCCC
After 39 days of this quarter the interest is at 82.0. Based on that we can calculate that during remaining 52 days it will total up to 191.0. C4 Therapeutics expected interest is significantly higher compared to same quarter last year (+91.0%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 52 | 91 75.0% QoQ | 58 -36.3% QoQ | 50 -13.8% QoQ |
| 2020 | 12 -76.9% YoY -76.0% QoQ | 72 -20.9% YoY 500.0% QoQ | 174 200.0% YoY 141.7% QoQ | 115 130.0% YoY -33.9% QoQ |
| 2021 | 76 533.3% YoY -33.9% QoQ | 99 37.5% YoY 30.3% QoQ | 58 -66.7% YoY -41.4% QoQ | 76 -33.9% YoY 31.0% QoQ |
| 2022 | 124 63.2% YoY 63.2% QoQ | 201 103.0% YoY 62.1% QoQ | 87 50.0% YoY -56.7% QoQ | 95 25.0% YoY 9.2% QoQ |
| 2023 | 100 -19.4% YoY 5.3% QoQ | 107 -46.8% YoY 7.0% QoQ | 96 10.3% YoY -10.3% QoQ | 210 121.1% YoY 118.8% QoQ |
| 2024 | 82 -18.0% YoY -61.0% QoQ | - | - | - |
The average 5 years interest of C4 Therapeutics was 7.8 per week. The last year interest of C4 Therapeutics compared to the last 5 years has changed by 34.1%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 106.72%.
There is not enough data for C4 Therapeutics cancer treatment to provide analysis
There is not enough data for C4 Therapeutics cancer treatment to provide correlation calculation
There is not enough data for C4 Therapeutics cancer treatment to provide analysis
There is not enough data for C4 Therapeutics neurodegenerative treatment to provide analysis
There is not enough data for C4 Therapeutics neurodegenerative treatment to provide correlation calculation
There is not enough data for C4 Therapeutics neurodegenerative treatment to provide analysis
There is not enough data for C4 Therapeutics Phase 1/2 trial to provide analysis
There is not enough data for C4 Therapeutics Phase 1/2 trial to provide correlation calculation
There is not enough data for C4 Therapeutics Phase 1/2 trial to provide analysis
There is not enough data for C4 Therapeutics protein degraders to provide analysis
There is not enough data for C4 Therapeutics protein degraders to provide correlation calculation
There is not enough data for C4 Therapeutics protein degraders to provide analysis
There is not enough data for C4 Therapeutics IKZF1 and IKZF3 to provide analysis
There is not enough data for C4 Therapeutics IKZF1 and IKZF3 to provide correlation calculation
There is not enough data for C4 Therapeutics IKZF1 and IKZF3 to provide analysis
There is not enough data for C4 Therapeutics therapeutic candidates to provide analysis
There is not enough data for C4 Therapeutics therapeutic candidates to provide correlation calculation
There is not enough data for C4 Therapeutics therapeutic candidates to provide analysis
After 92 days of this quarter the interest is at 110.0. Based on that we can calculate that during remaining 0 days it will total up to 110.0. C4 Therapeutics stock expected interest is significantly higher compared to previous quarter (+107.5%) but similar to same quarter last year.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2018 | - | - | - | 76 |
| 2019 | 93 22.4% QoQ | 0 -100.0% QoQ | 0 -100.0% QoQ | 325 327.6% YoY inf% QoQ |
| 2020 | 0 -100.0% YoY -100.0% QoQ | 127 inf% YoY inf% QoQ | 0 inf% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2021 | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ | 0 -100.0% YoY -100.0% QoQ |
| 2022 | 41 inf% YoY inf% QoQ | 190 inf% YoY 363.4% QoQ | 162 inf% YoY -14.7% QoQ | 92 inf% YoY -43.2% QoQ |
| 2023 | 91 122.0% YoY -1.1% QoQ | 53 -72.1% YoY -41.8% QoQ | 110 -32.1% YoY 107.5% QoQ | 104 13.0% YoY -5.5% QoQ |
The average 5 years interest of C4 Therapeutics stock was 5.63 per week. The last year interest of C4 Therapeutics stock compared to the last 5 years has changed by 36.59%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 58.56%.
There is not enough data for C4 Therapeutics jobs to provide analysis
There is not enough data for C4 Therapeutics jobs to provide correlation calculation
There is not enough data for C4 Therapeutics jobs to provide analysis
After 39 days of this quarter the interest is at 63.0. Based on that we can calculate that during remaining 52 days it will total up to 147.0. C4 Therapeutics -company expected interest is significantly higher compared to same quarter last year (+61.5%) but similar to previous quarter.
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | 48 | 82 70.8% QoQ | 62 -24.4% QoQ | 26 -58.1% QoQ |
| 2020 | 72 50.0% YoY 176.9% QoQ | 77 -6.1% YoY 6.9% QoQ | 155 150.0% YoY 101.3% QoQ | 129 396.2% YoY -16.8% QoQ |
| 2021 | 93 29.2% YoY -27.9% QoQ | 83 7.8% YoY -10.8% QoQ | 105 -32.3% YoY 26.5% QoQ | 101 -21.7% YoY -3.8% QoQ |
| 2022 | 121 30.1% YoY 19.8% QoQ | 201 142.2% YoY 66.1% QoQ | 83 -21.0% YoY -58.7% QoQ | 66 -34.7% YoY -20.5% QoQ |
| 2023 | 91 -24.8% YoY 37.9% QoQ | 107 -46.8% YoY 17.6% QoQ | 89 7.2% YoY -16.8% QoQ | 242 266.7% YoY 171.9% QoQ |
| 2024 | 63 -30.8% YoY -74.0% QoQ | - | - | - |
The average 5 years interest of C4 Therapeutics -company was 8.03 per week. The last year interest of C4 Therapeutics -company compared to the last 5 years has changed by 33.87%. This is something to be checked. The last year interest is quite higher compared to 5 years ago. It has increased by 119.39%.